Literature DB >> 11486310

Randomized trial experience of the Intergroupe Francophone du Myélome.

M Attal1, J L Harousseau.   

Abstract

This article summarizes clinical results of the Intergroupe Francophone du Myélome (IFM) trials: high-dose therapy (HDT) supported with autologous stem cells improves survival, melphalan 200 mg/m(2) is the best preparative regimen, unpurged peripheral blood stem cells (PBSC) are the recommended source of stem cells to support HDT, and tandem transplants significantly improve survival. Although these results are encouraging, the current IFM 99 protocol will evaluate innovative strategies with the goal to improve long-term survival.

Mesh：

Substances：

Year:  2001        PMID： 11486310     DOI： 10.1016/s0037-1963(01)90014-9

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


  6 in total

Review 1.  Current status of stem cell transplantation for multiple myeloma.

Authors:  Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Suzanne Hayman
Journal:  Curr Treat Options Oncol       Date:  2005-05

2.  Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo.

Authors:  Makoto Hamasaki; Teru Hideshima; Pierfrancesco Tassone; Paola Neri; Kenji Ishitsuka; Hiroshi Yasui; Norihiko Shiraishi; Noopur Raje; Shaji Kumar; Donald H Picker; Gary S Jacob; Paul G Richardson; Nikhil C Munshi; Kenneth C Anderson
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

Review 3.  Breakthroughs in the management of multiple myeloma.

Authors:  Leonard T Heffner; Sagar Lonial
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Evolving role of high dose stem cell therapy in multiple myeloma.

Authors:  Ajay Gupta; Lalit Kumar
Journal:  Indian J Med Paediatr Oncol       Date:  2011-01

Review 5.  An update of novel therapeutic approaches for multiple myeloma.

Authors:  Paul Richardson; Teru Hideshima; Kenneth C Anderson
Journal:  Curr Treat Options Oncol       Date:  2004-06

6.  Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001-2010: a retrospective, population based analysis.

Authors:  Jon-Magnus Tangen; Geir Erland Tjønnfjord; Nina Gulbrandsen; Tobias Gedde-Dahl; Espen Stormorken; Kristina Anderson; Camilla Dao Vo; Fredrik Hellem Schjesvold
Journal:  BMC Cancer       Date:  2018-08-08       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.